Paolo Morazzoni

This inventor holds 56 USPTO granted patents and 6 published patent applications, plus 18 CIPO patents and 17 EPO patents, primarily in Pharmaceutical Formulations (CPC class A61K). Top assignees: Indena S.p.a., I D B Holding S.p.a.. Active years: 1994-2026.

USPTO Granted Patents = 56 (Patent Applications = 6)

% Patents Active = 53.6

CIPO Patents = 18 (Patent Applications = 3)

EPO Patents = 17 (Patent Applications = 20)

Average Co-Inventor Count = 2.8

ph-index = 9

Forward Citations = 264(Granted Patents)

Forward Citations (Not Self Cited) = 256(Dec 10, 2025)

Inventors with similar research interests:

Company Filing History:

Years Active: 1994-2026

Loading Chart...

Areas of Expertise:

Isothiocyanate Derivatives

Peripheral Pain Modulators

Alzheimer's Disease

Chronic Inflammatory Conditions

Antitumoral Agents

Hyperforin Derivatives

Echinacea Extracts

Diabetes Treatments

Antimicrobial Activity

Cognitive Function Enhancement

Mucositis Treatment

Respiratory Tract Disorders

56 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12673079 - Compositions comprising an American cranberry extract and phospholipids (2026-07-07),

2. 11026984 - Use of isothiocyanate derivatives as modulators of peripheral and neuropathic pain (2021-06-08),

3. 10016478 - Combinations of extracts of serenoa repens and lipophilic extracts of zingiber officinalis and echinacea angustifolia, the use thereof, and formulations containing them (2018-07-10),

4. 9839663 - [object Object] (2017-12-12),

5. 9770475 - Compositions for the treatment of peripheral ulcers of various origins (2017-09-26),

6. 9730974 - [object Object] (2017-08-15),

7. 9730952 - Methods for treating and preventing mucositis (2017-08-15),

8. 9556099 - Hyperforin derivatives and their use in Alzheimer's disease (2017-01-31),

9. 9393280 - Formulations with sanguinarine, chelerythrine or chelidonine for the treatment of warts, verrucas and psoriatic plaques (2016-07-19),

10. 9283259 - [object Object] (2016-03-15),

11. 9168276 - Formulations for the treatment of disorders of the upper respiratory tract (2015-10-27),

12. 8772251 - Use of isothiocyanate derivatives as anti-myeloma agents (2014-07-08),

13. 8591965 - Use of a ginkgo complexes for the enhancement of cognitive functions and the alleviation of mental fatigue (2013-11-26),

14. 8569455 - Cloning, yeast expression, purification and biological activity of the extension region of the soybean 7S globulin alfa' subunit involved in HEP G2 cell cholesterol homeostasis (2013-10-29),

15. 8496975 - Compositions for the treatment and prevention of infections of the oral cavity (2013-07-30),

Title: **The Innovations of Paolo Morazzoni: A Pioneer in Pain Modulation**

Introduction

Paolo Morazzoni, an esteemed inventor based in Milan, Italy, has made remarkable contributions to the field of pain modulation with a total of 55 patents. His extensive work reflects a commitment to advancing medical innovations, particularly focusing on addressing peripheral and neuropathic pain.

Latest Patents

Among his latest patents, Morazzoni has developed innovative uses for isothiocyanate derivatives as modulators of peripheral and neuropathic pain. His invention highlights the use of glucomoringin (GMG) and its derivative, glucomoringin des-thioglucoside (GMG-ITC), to target pain associated with diabetic peripheral neuropathy and chemotherapy-induced neuropathy. Additionally, he has disclosed combinations of extracts from serenoa repens, with lipophilic extracts of zingiber officinalis and echinacea angustifolia, showcasing a unique approach to formulating effective pain relief compositions.

Career Highlights

Morazzoni’s career is complemented by his work with reputable companies, notably Indena S.p.A. and Indena S.A., where he has collaborated on groundbreaking projects aimed at enhancing therapeutic solutions for pain management. His extensive patent portfolio underlines his role as a leader in innovation within the pharmaceutical industry.

Collaborations

Throughout his career, Morazzoni has collaborated with other eminent professionals, including Ezio Bombardelli and Antonella Riva. These partnerships have fostered a rich environment for the exchange of ideas and expertise, further propelling advancements in pain management therapies.

Conclusion

Paolo Morazzoni's contributions to innovations in pain modulation represent a significant step forward in medical treatment options. His extensive patent portfolio and collaborative efforts demonstrate his dedication to creating effective solutions for those suffering from chronic pain. As he continues to innovate, Morazzoni remains an influential figure in the realm of pharmaceutical advancements.